Anil Chandraker

Chief, Division of Renal Medicine · UMass Chan Medical School

Credentials: · ·

History

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Nature Medicine · 2007 · 1,882 citations
The promise of organ and tissue preservation to transform medicine
Review · Nature Biotechnology · 2017 · 380 citations
Role of the PD-1 pathway in the immune response
Review · American Journal of Transplantation · 2012 · Last of 4 authors · 366 citations

Novel Therapies to Improve Renal and Cardiac Allograft Outcomes
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.5M · Brigham and Women's Hospital
2004–2015
Clinical Characterization of the APOL1-Associated Phenotype
National Institute of Diabetes and Digestive and Kidney Diseases · R24
PI · $492.9K · Beth Israel Deaconess Medical Center
2011–2013
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $7.7K · Brigham and Women's Hospital
2007–2008
The CD40-CD154 Pathway in Chronic Allograft Rejection
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $621K · Brigham and Women's Hospital
2001–2007

Lipid Management in Renal Transplant Recipients Using Evolocumab.
Principal investigator · Completed · Phase 4
Brigham and Women's Hospital
2021–2025
APOL1 Gene Variants in African American Kidney Transplant Recipients
Principal investigator · Terminated
Brigham and Women's Hospital
2014
Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
Principal investigator · Terminated · Phase 2
Brigham and Women's Hospital
2013–2016
Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
Principal investigator · Terminated · Phase 4
Brigham and Women's Hospital
2010–2012